Involvement of intracellular vesicular trafficking in toxicity of anticancer drugs
| Project/Area Number |
23790171
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 制がん剤 / 細胞内小胞輸送経路 / エンドサイトーシス / 癌 / 遺伝子 |
|---|
| Research Abstract |
We examined the relationship between intracellular transport pathways and adriamycin toxicity, and found that defect of genes for endoplasmic reticulum (ER)-to-golgi transport enhanced adriamycin toxicity. We also found that disruption of Erv14, one of the cargo receptors involved in ER-to-golgi transport, conferred hypersensitivity to adriamycin. Our results suggest that Erv14 dependent ER-to-golgi transport system plays a major role in the defense mechanism against toxicity of adriamycin.
|
Report
(3 results)
Research Products
(15 results)
